banner add

New Eli Lilly Drug Retatrutide Brought Major Weight Loss in Trial

The maker of Zepbound reported results from a study of retatrutide, which targets three hormones in the body and led to much more weight loss than any approved drug.

from NYT > Health https://ift.tt/CVf3hlU
via IFTTT

No comments

UnitedHealth Group Reports Flat First-Quarter Earnings

One of the nation’s largest insurers, the company’s profits were higher than analysts’ expectations but still fell short of showing a signif...

Theme images by PLAINVIEW. Powered by Blogger.